Cargando…

Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19

The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from al...

Descripción completa

Detalles Bibliográficos
Autores principales: Amad, A., Magnat, M., Quilès, C., Yrondi, A., Sauvaget, A., Bulteau, S., Plaze, M., Rotharmel, M., Polosan, M., Lévy-Chavagnat, D., Jaafari, N., Vaiva, G., Thomas, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: L'Encéphale, Paris. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174183/
https://www.ncbi.nlm.nih.gov/pubmed/32370981
http://dx.doi.org/10.1016/j.encep.2020.04.004
_version_ 1783524581336678400
author Amad, A.
Magnat, M.
Quilès, C.
Yrondi, A.
Sauvaget, A.
Bulteau, S.
Plaze, M.
Rotharmel, M.
Polosan, M.
Lévy-Chavagnat, D.
Jaafari, N.
Vaiva, G.
Thomas, P.
author_facet Amad, A.
Magnat, M.
Quilès, C.
Yrondi, A.
Sauvaget, A.
Bulteau, S.
Plaze, M.
Rotharmel, M.
Polosan, M.
Lévy-Chavagnat, D.
Jaafari, N.
Vaiva, G.
Thomas, P.
author_sort Amad, A.
collection PubMed
description The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from all over France were analysed. More than 90 % of the centres practising ECT experienced a decrease in their activity. Half of the centres experienced a total cessation of activity and 25 % of the centres experienced a decrease of more than half of their usual activity. Post-pandemic COVID-19 psychiatric care is expected to be difficult. It is essential not to add to this difficulty the complications, often serious, that will be associated with delaying or stopping the practice of ECT. It will also be necessary to remain vigilant with regard to the specific neuropsychiatric consequences that will follow the pandemic.
format Online
Article
Text
id pubmed-7174183
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher L'Encéphale, Paris.
record_format MEDLINE/PubMed
spelling pubmed-71741832020-04-22 Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19 Amad, A. Magnat, M. Quilès, C. Yrondi, A. Sauvaget, A. Bulteau, S. Plaze, M. Rotharmel, M. Polosan, M. Lévy-Chavagnat, D. Jaafari, N. Vaiva, G. Thomas, P. Encephale Article The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from all over France were analysed. More than 90 % of the centres practising ECT experienced a decrease in their activity. Half of the centres experienced a total cessation of activity and 25 % of the centres experienced a decrease of more than half of their usual activity. Post-pandemic COVID-19 psychiatric care is expected to be difficult. It is essential not to add to this difficulty the complications, often serious, that will be associated with delaying or stopping the practice of ECT. It will also be necessary to remain vigilant with regard to the specific neuropsychiatric consequences that will follow the pandemic. L'Encéphale, Paris. 2020-06 2020-04-22 /pmc/articles/PMC7174183/ /pubmed/32370981 http://dx.doi.org/10.1016/j.encep.2020.04.004 Text en © 2020 L'Encéphale, Paris. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Amad, A.
Magnat, M.
Quilès, C.
Yrondi, A.
Sauvaget, A.
Bulteau, S.
Plaze, M.
Rotharmel, M.
Polosan, M.
Lévy-Chavagnat, D.
Jaafari, N.
Vaiva, G.
Thomas, P.
Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19
title Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19
title_full Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19
title_fullStr Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19
title_full_unstemmed Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19
title_short Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19
title_sort évolution de l’activité d’électro-convulsivo-thérapie en france depuis le début de la pandémie covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174183/
https://www.ncbi.nlm.nih.gov/pubmed/32370981
http://dx.doi.org/10.1016/j.encep.2020.04.004
work_keys_str_mv AT amada evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT magnatm evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT quilesc evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT yrondia evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT sauvageta evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT bulteaus evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT plazem evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT rotharmelm evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT polosanm evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT levychavagnatd evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT jaafarin evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT vaivag evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19
AT thomasp evolutiondelactivitedelectroconvulsivotherapieenfrancedepuisledebutdelapandemiecovid19